Demonstrating consistent activity in handling high-profile multibillion-dollar M&A, with particular expertise in the pharmaceutical and manufacturing industries, the Fried, Frank, Harris, Shriver & Jacobson LLP team is highly praised for providing ‘creative solutions’ to its roster of domestic and international corporate clients. Philip Richter and Steven Epstein jointly head up the New York-based practice, with the former being an expert in complex strategic partnerships and joint ventures, while the latter primarily handles divestitures and IPOs. Matthew Soran specialises in growth and venture capital investments and recapitalizations, while Roy Tannenbaum focuses on corporate restructurings and cash tender offers. Amber Banks and Brian Mangino departed the firm in September 2023.
Testimonials
Collated independently by Legal 500 research team.
‘We worked with FF on a potential M&A transaction. The team was able to provide creative solutions while dealing with a difficult counterparty. Good integration of the M&A team with the other parts of the firm that had to be brought in (tax, executive comp, etc.).’
Key clients
- Aerie Pharmaceuticals
- Ascential plc
Work highlights
- Advised Kimco Realty Corporation in connection with the $24.6bn definitive merger agreement between the Kroger and Albertsons retail chains.
- Advised a consortium of investors that included Permira and Hellman & Friedman in their $10.2bn acquisition of Zendesk in an all-cash, take-private transaction.